KLRK1 and neoplasm: In addition to the direct enhancement of NKG2D on cell subsets to generate potent cytotoxic effector cells using Cas9 genetic editing, potential exists to use dCas9-based epigenetic editing methods to activate and lock NKG2D-L expression on tumor or virus-infected cells to promote their recognition and elimination.